Range of suitable people: CDEC talked over the uncertainty in the volume of individuals with reasonably significant to critical hemophilia B in Canada qualified for etranacogene dezaparvovec. Clinical professionals consulted by CADTH indicated that some sufferers who are classified as having moderate or average illness might have a severe bleeding … Read More